Literature DB >> 12905493

Cytokines elicited by T cell epitopes from a synovial autoantigen: altered peptide ligands can reduce interferon-gamma and interleukin-10 production.

Frances C Hall1, Kevin C Visconti, Regina-Celeste Ahmad, Sarah L Parry, André M M Miltenburg, Harden M McConnell, Elizabeth D Mellins, Grete Sønderstrup.   

Abstract

OBJECTIVE: To explore the cytokine responses associated with T cell epitopes from human cartilage glycoprotein 39 (HC gp-39) and the potential for modifying cytokine secretion using altered peptide ligands (APLs).
METHODS: Draining lymph node cells were harvested from HLA-DR*0401 transgenic mice that had been immunized with HC gp-39. Cytokine responses to 5 previously identified HLA-DR*0401-restricted HC gp-39 T cell epitopes were studied in vitro. The anchor and T cell receptor (TCR) contact residues of peptide 322-337 were identified, and this information was used to design alanine-substituted APLs. T cells were primed in vivo with wild-type peptide 322-337, restimulated with wild-type peptide or APLs, and the cytokine profiles were compared.
RESULTS: Restimulation with individual peptides elicited distinct cytokine profiles. HC gp-39 (peptide 322-337) elicited a dominant interferon-gamma (IFNgamma) response. Residues within the core (positions P1-P9) 322-337 peptide sequence were critical for T cell recognition. Surprisingly, the N-terminal flanking region was also important for recognition by 6 of 10 specific T cell hybridomas. Substitutions of charged TCR contact residues in the 322-337 core epitope (E332A and K335A) were associated with a significant reduction in the IFNgamma and interleukin-10 (IL-10) stimulation indices. Restimulation with peptides W325A and V326A was also associated with a trend toward reduced IFNgamma and IL-10 secretion. In contrast, restimulation with peptide D330N elicited cytokine profiles more comparable with those resulting from restimulation with wild-type peptide.
CONCLUSION: This study indicates that APLs of a proinflammatory HC gp-39 T cell epitope may be used to alter the cytokine response from a memory T cell population.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12905493     DOI: 10.1002/art.11132

Source DB:  PubMed          Journal:  Arthritis Rheum        ISSN: 0004-3591


  3 in total

1.  DRB1*0401-restricted human T cell clone specific for the major proinsulin73-90 epitope expresses a down-regulatory T helper 2 phenotype.

Authors:  Ivana Durinovic-Belló; Silke Rosinger; Jennifer A Olson; Mauro Congia; Regina C Ahmad; Mathias Rickert; Johannes Hampl; Hubert Kalbacher; Jan W Drijfhout; Elizabeth D Mellins; Sascha Al Dahouk; Thomas Kamradt; Markus J Maeurer; Carol Nhan; Bart O Roep; Bernhard O Boehm; Constantin Polychronakos; Gerald T Nepom; Wolfram Karges; Hugh O McDevitt; Grete Sønderstrup
Journal:  Proc Natl Acad Sci U S A       Date:  2006-07-25       Impact factor: 11.205

2.  Identification of an altered peptide ligand based on the endogenously presented, rheumatoid arthritis-associated, human cartilage glycoprotein-39(263-275) epitope: an MHC anchor variant peptide for immune modulation.

Authors:  Annemieke M H Boots; Henk Hubers; Milou Kouwijzer; Leontien den Hoed-van Zandbrink; Bernice M Westrek-Esselink; Cindy van Doorn; Rachel Stenger; Ebo S Bos; Marie-jose C van Lierop; Gijs F Verheijden; Cornelis M Timmers; Catharina J van Staveren
Journal:  Arthritis Res Ther       Date:  2007       Impact factor: 5.156

3.  A CD4+ T cell antagonist epitope down-regulates activating signaling proteins, up-regulates inhibitory signaling proteins and abrogates HIV-specific T cell function.

Authors:  Evan S Jacobs; Desmond Persad; Longsi Ran; Ali Danesh; John W Heitman; Xutao Deng; Mark J Cameron; David J Kelvin; Philip J Norris
Journal:  Retrovirology       Date:  2014-07-05       Impact factor: 4.602

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.